2020 IPO
SQZ Biotech Stock
SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies.
Sign up today and learn more about SQZ Biotech Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About SQZ Biotech Stock
SQZ Biotechnologies is a Massachusetts-based, privately held company developing cellular therapies for multiple indications using the proprietary CellSqueeze® technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.
Investors
NanoDimension
Funding History
| April 2014 | $15K |
|---|---|
| October 2014 | $100K |
| June 2015 | $5.0M |
| September 2016 | $16.0M |
| December 2016 | $8.3M |
| August 2018 | $72.0M |
Management
Director of Strategic Scientific Partnerships
Jonathan Gilbert
CEO
Armon Sharei
Chief Scientific Officer
Howard Bernstein
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
